4
Changes in Ownership
Sarepta Therapeutics, Inc. Filed Acc 0001209191-19-061049
EVP, General Counsel sold 78,000 shares at $125.50 ($9,789,000)
- EVP, General Counsel acquired 78,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Howton David T · EVP, General Counsel
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-12-13 | Exercise or conversion : show line 1 in the form | +18,579 | $13.90 | $258,248 | 43,750 | D |
| 2019-12-13 | Exercise or conversion : show line 2 in the form | +59,421 | $23.85 | $1,417,191 | 103,171 | D |
| 2019-12-13 | Sale : show line 3 in the form | −78,000 | $125.50 | $9,789,000 | 25,171 | D |
| Open-market sales · 78,000 sh · avg $125.50 · $9,789,000 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-12-13 | Exercise or conversion : show line 4 in the form Stock option (right to buy) | −18,579 | $13.90 | 2025-02-27 | 18,579 | 0 | D |
| 2019-12-13 | Exercise or conversion : show line 5 in the form Stock option (right to buy) | −59,421 | $23.85 | 2022-11-05 | 59,421 | 56,984 | D |
Loading xslF345X03/doc4.xml…